US$ 21.18
glp-1 pregnancy From JAMA: #GLP-1 receptor agonist exposure with discontinuation before or during early #pregnancy was associated with greater gestational weight gain and increased risk of preterm delivery, gestational #diabetes, and hypertensive disorders. https://ja GLP-1 Receptor Agonists in Pregnancy
Description
Ozempic/semaglutide is the one thats been all over the news lately, but look for mounjaro/tirzepatide coming down the pike

& Murphy, K

Itll balance access to the drug with guardrails, she said.

FDA approvals now encompass chronic kidney disease indications for some agents, obstructive sleep apnea treatment and metabolic dysfunction associated steatotic liver disease for select products
